ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "physical function"

  • Abstract Number: 0899 • ACR Convergence 2022

    Performance of the Foot Function Index Questionnaire in Patients with Rheumatoid Arthritis

    Joan Manuel Dapeña, Lucia Alascio, Eliana Rebeca Serrano, Juan Manuel Bande, Maria Alejandra Medina, Diana Silvia Klajn, Jose Angel Caracciolo and Silvia Beatriz Papasidero, Hospital General de Agudos Dr. Enrique Tornu, Buenos Aires, Argentina

    Background/Purpose: Multiple questionnaires and objective assessment tools have been developed to determine functional compromise in Rheumatoid Arthritis (RA). One of the most used tools to…
  • Abstract Number: 1198 • ACR Convergence 2022

    Validation of Remote Physical Performance and Cognitive Functioning Measures Among Individuals with Systemic Lupus Erythematosus

    Courtney Hoge1, C. Barrett Bowling2, Charmayne Dunlop-Thomas1, Bradley Pearce1, S. Sam Lim1, Cristina Drenkard1 and Laura Plantinga1, 1Emory University, Atlanta, GA, 2Duke University, Durham, NC

    Background/Purpose: The disruption of the COVID-19 pandemic presented an opportunity for researchers to develop and administer remote versions of measures for ongoing studies. In an…
  • Abstract Number: 1307 • ACR Convergence 2022

    Effect of Romosozumab in Postmenopausal Women with Knee Osteoarthritis: Results from the FRAME Clinical Trial

    Nancy Lane1, Donald Betah2, Cynthia Deignan2, Mary Oates2, Zhenxun Wang2, Jen Timoshenko3, Aliya Khan4 and Neil Binkley5, 1University of California Davis, Hillsborough, CA, 2Amgen, Inc., Thousand Oaks, CA, 3UCB Pharma, Slough, United Kingdom, 4McMaster University, Oakville, ON, Canada, 5University of Wisconsin, Madison, WI

    Background/Purpose: Osteoarthritis (OA) and osteoporosis (OP) often occur concomitantly in the elderly. The relationship between OA and OP is complex, with increased fracture risk reported…
  • Abstract Number: 1491 • ACR Convergence 2022

    Clinically Relevant Differences in the Mobility of Patients with Axial Spondyloarthritis Related to Daytime of Performance

    David Kiefer1, Juergen Braun1, Lucia Schneider1, Niklas Kolle1, Uta Kiltz1, Ioana Andreica2, Philipp Sewerin1, Bjoern Buehring3, susanne herbold1 and Xenofon Baraliakos4, 1Rheumazentrum Ruhrgebiet, Herne, Germany, 2Rheumazentrum Ruhrgebiet, Ruhr-Universität-Bochum, Herne, Germany, 3Bergisches Rheuma-Zentrum, Velbert, Germany, 4Rheumazentrum Ruhrgebiet Herne, Herne, Germany

    Background/Purpose: Patients with axial spondyloarthritis (axSpA) often experience impairments of spinal mobility and physical function due to inflammation and structural damage. Back pain and morning…
  • Abstract Number: 1507 • ACR Convergence 2022

    Diagnostic Delay of More Than 6 Months Contributes to Poor Patient-Reported Outcome Measures in Psoriatic Arthritis

    Neel Tapryal1, George Gondo2, M. Elaine Husni3, Alice Gottlieb4 and Joseph Merola5, 1Cleveland Clinic, Rocky River, OH, 2National Psoriasis Foundation, Portland, OR, 3Cleveland Clinic, Cleveland, OH, 4Department of Dermatology, The Icahn School of Medicine at Mount Sinai, New York, NY, 5Harvard Medical School, Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Psoriatic arthritis (PsA) is a type of inflammatory arthritis in which the time between symptom onset and a diagnosis of PsA is highly variable.…
  • Abstract Number: 1617 • ACR Convergence 2021

    Burden of Adverse Childhood Experiences in Pediatric Chronic Pain and Rheumatic Disease

    Maitry Sonagra1, Jeremy Jones2, Mackenzie McGill3 and Sabrina Gmuca3, 1Seattle Children's Hospital, Seattle, WA, 2University of Pennsylvania, Philadelphia, PA, 3Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: Adverse childhood experiences (ACEs) serve as stressors that can have negative, lasting effects on health and wellbeing. While there has been increasing evidence to…
  • Abstract Number: 1664 • ACR Convergence 2021

    Changes in Physical Function Were Not Associated with Clinically Important Changes in Muscle Strength or Physical Performance over Time – A Cohort Study

    Rafaela Espírito Santo1, Joshua Baker2, Jordana Silva3, Lidiane Filippin4, Juliana Portes1, Claiton Brenol1, Rafael Chakr5 and Ricardo Xavier6, 1Hospital de Clínicas de Porto Alegre, Laboratório de Doenças Autoimunes, Serviço de Reumatologia, Porto Alegre, Brazil; Universidade Federal do Rio Grande do Sul, Faculdade de Medicina, Porto Alegre, Brazil, 2University of Pennsylvania, Philadelphia, PA, 3Institute of musculoskeletal medicine, University Hospital Munster, Munster, Germany, 4Universidade La Salle, Canoas, Brazil, 5Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil, 6Departamento de Reumatologia, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil

    Background/Purpose: The Health Assessment Questionnaire Disability Index (HAQ) is negatively associated with muscle strength by handgrip test and positively associated with physical performance by timed…
  • Abstract Number: 0122 • ACR Convergence 2021

    Clinical Impact of a Digital Behavioral Therapy for Fibromyalgia Management: A Randomized Controlled Trial

    Stephanie Catella1, Michael Gendreau2, Nicolette Vega1, Allison Kraus1, Michael Rosenbluth1, Sherry Soefje3, Shishuka Malhotra4 and Lesley Arnold5, 1Swing Therapeutics, San Francisco, CA, 2Gendreau Consulting, LLC, Poway, CA, 3Excell Research, Oceanside, CA, 4Neuro-Behavioral Clinical Research, North Canton, OH, 5University of Cincinnati, Cincinnati, OH

    Background/Purpose: Recommendations for fibromyalgia management include both pharmacologic and nonpharmacologic treatments. Cognitive behavioral therapy (CBT) has demonstrated level 1A evidence for fibromyalgia management, though access…
  • Abstract Number: 1903 • ACR Convergence 2021

    Does Limited Stair Climbing Lead to Poor Future Health? The Relationship Between Short-term Trajectories of Stair Climbing Frequency and Incident Slow Gait Speed over 1 and 2 Years in Adults with Knee Osteoarthritis

    Jason Jakiela1, Yuqing Zhang2, Dana Voinier1, Thomas Bye1, Jennifer Copson1 and Daniel White1, 1University of Delaware, Newark, DE, 2Massachusetts General Hospital, Quincy, MA

    Background/Purpose: Knee osteoarthritis (OA) is a common cause of functional limitation in older adults, and difficulty with climbing stairs is one of the first limitations…
  • Abstract Number: 0222 • ACR Convergence 2021

    Effects of Multi-Joint Osteoarthritis Phenotypes on Self-Reported Physical Function over 3.5 Years: The Johnston County Osteoarthritis Project

    Amanda Nelson1, Carolina Alvarez1, Liubov Arbeeva1, Jordan Renner1, Virginia Kraus2, Duncan Lascelles3 and Yvonne Golightly1, 1University of North Carolina at Chapel Hill, Chapel Hill, NC, 2Duke University, Durham, NC, 3North Carolina State University, Raleigh, NC

    Background/Purpose: To determine the differential effects of several literature-based definitions of multi-joint osteoarthritis (MJOA) on change in self-reported physical function in a community-based cohort.Methods: We…
  • Abstract Number: 0224 • ACR Convergence 2021

    Effects of Kinesiophobia and Physical Function on Physical Activity in Adults with Knee Osteoarthritis

    Burcu Aydemir and Kharma Foucher, University of Illinois at Chicago, Chicago, IL

    Background/Purpose: Only a small proportion of people with knee osteoarthritis (OA) meet the recommended guidelines for physical activity and it is still unclear why. Lacking…
  • Abstract Number: 0235 • ACR Convergence 2021

    Are Comorbidities in Patients with Chronic Inflammatory Rheumatic Diseases Associated with Treatment Adherence to Biosimilars in a Non-medical Switch Scenario?

    Imke Redeker1, Stefan Moustakis2, Styliani Tsiami2, Xenofon Baraliakos2, Ioana Andreica2, Bjoern Buehring2, Juergen Braun2 and Uta Kiltz2, 1German Rheumatism Research Centre (DRFZ), Berlin, Germany, 2Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany

    Background/Purpose: The availability of biosimilars has created a financial incentive to encourage non-medical switching if cheaper products are on the market. In patients with chronic…
  • Abstract Number: 0358 • ACR Convergence 2021

    Work Participation in Patients with Axial Spondyloarthritis in Germany: Results from a Multicenter, Observational Survey

    Uta Kiltz1, Kirsten Hoeper2, Ludwig Hammel3, Sebastian Lieb4, Andreas Haehle4 and Dirk Meyer-Olson5, 1Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany, 2Regionales Kooperatives Rheumazentrum Niedersachsen e. V.; Medizinische Hochschule Hannover, Department of Rheumatology and Immunology, Hannover, Germany,, Hannover, Germany, 3Deutsche Vereinigung Morbus Bechterew e.V.,, Schweinfurt, Germany, 4Novartis Pharma GmbH, Immunology, Hepatology and Dermatology, Nürnberg, Germany, 5m&i Fachklinik Bad Pyrmont, Hannover, Germany

    Background/Purpose: Axial spondyloarthritis (axSpA) is a chronic inflammatory condition often associated with impaired working participation1 not only translating to devastating outcomes for patients (pts) but…
  • Abstract Number: 0376 • ACR Convergence 2021

    Impact of Patient and Disease Characteristics on Global Functioning and Health in Patients with Axial Spondyloarthritis: A Bayesian Network Analysis of Data from an Early axSpA Cohort

    Imke Redeker1, Robert Landewé2, Désirée van der Heijde3, Sofia Ramiro4, Annelies Boonen5, Maxime Dougados6, Juergen Braun7 and Uta Kiltz7, 1German Rheumatism Research Centre (DRFZ), Berlin, Germany, 2Amsterdam Rheumatology & Clinical Immunology Center, Amsterdam, Netherlands; Zuyderland MC, Heerlen, Netherlands, 3Department of Rheumatology, Leiden University Medical Center, Meerssen, Netherlands, 4Leiden University Medical Center, Leiden, Netherlands, 5Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre+ (MUMC+), Maastricht, Limburg, Netherlands, 6Université de Paris . Department of Rheumatology - Hôpital Cochin. Assistance Publique - Hôpitaux de Paris . INSERM (U1153): Clinical epidemiology and biostatistics, PRES Sorbonne Paris-Cité. Paris, France., Paris, France, 7Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany

    Background/Purpose: Current knowledge on the health status of patients (pts.) with axial spondyloarthritis (axSpA) mainly focusses on physical function and disease activity. Using a generic…
  • Abstract Number: 0735 • ACR Convergence 2021

    Walking Ability 12 Months After Total Knee Arthroplasty for Osteoarthritis – Gap Between Expectations and Reality: The BEST Knee Cohort Study

    Lauren King, Esther Waugh and Gillian Hawker, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Improved ability to walk is a key driver for people with knee osteoarthritis (OA) to seek total knee arthroplasty (TKA). However, the extent to…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 9
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology